Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling with BTX-A vs Meso-Botox for Atrophic Acne Scars
NCT06544993Recruiting
- Sponsor
- Sohag University
- Start
- May 2024
- Primary completion
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in atrophic acne scars (2 arms), sponsored by Sohag University. Primary endpoint: Goodman and Baron Qualitative Global Scarring Grading System at 6 months. Started May 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
atrophic acne scars
Beyond the preview
Go deeper on NCT06544993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06544993.